News

A federal judge rejected a bid by compounding pharmacies to continue selling versions of weight-loss drug Wegovy and diabetes ...
This week in Ozempic news: No more compounded GLP-1s, weight-loss pills are coming, and WeightWatchers is filing for ...
Novo Nordisk (NVO) has launched its weight-loss drug Wegovy in Thailand, Reuters reported on Monday, citing an executive of ...
Many compounding pharmacies are no longer allowed to make cheaper versions of semaglutide and other GLP-1 drugs. A doctor ...
Novo Nordisk (NVO) announced on Friday that it has secured a legal victory against compounders selling unauthorized versions ...
Federal law allows compounding pharmacies to make copies of name brand drugs while there’s a supply shortage. But there's a ...
Patients flocked to those Ozempic, Wegovy copycats when the branded drugs were in short supply, or if they didn’t have ...
Novo Nordisk has notched a major legal win against compounding pharmacies that make copies of its diabetes and obesity drug ...
Ozempic (semaglutide) and Wegovy (semaglutide) are prescription drugs that may be used to help with long-term weight loss. But only Wegovy is FDA approved for this use. Both drugs are approved for ...
Novo Nordisk scored a legal win against compounders of its blockbuster GLP-1 drugs. But it may not end the copycats.
A federal judge in Texas handed Novo Nordisk (NVO) a big win late Thursday in its battle against cheaper versions of its ...
Now, alarmed by sunken features and sagging skin, newly svelte patients are flooding med spas and plastic surgery clinics, desperate to plump, lift and smooth their way back to a youthful glow. These ...